UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
July 7, 2004
Date of report (Date of earliest event reported)
ENCORE MEDICAL CORPORATION
(Exact name of Registrant as Specified in Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| 000-26538 | | 65-0572565 |
| (Commission File Number) | | (IRS Employer Identification No.) |
| 9800 Metric Blvd., Austin, Texas | | 78758 |
| (Address of Principal Executive Offices) | | (Zip Code) |
(512) 832-9500
(Registrant’s telephone
number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Item 5 Other Events and Required FD Disclosure
On July 2, 2004, Encore Medical Corporation (“ENMC”) announced that Mr. August Faske, Encore’s Chief Financial Officer, has announced his retirement which will be effective on or before August 31, 2004. Simultaneously, Encore announced that Mr. William W. Burke will be the new Chief Financial Officer, effective on or before August 31, 2004.
A copy of the press release announcing these actions is attached to this Form 8-K as Exhibit 99.1 and is hereby incorporated by reference herein.
Item 7. Financial Statements and Exhibits (c) Exhibits.
99.1 Press Release dated July 2, 2004
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|---|
| ENCORE MEDICAL CORPORATION |
| |
| |
| Date: July 7, 2004 | By:/s/ Harry L. Zimmerman |
| | Harry L. Zimmerman |
| | Executive Vice President - General Counsel |
